SCOPUS 정보 검색 플랫폼

Archives of Pharmacal Research

Volumn 31, Issue 8, 2008, Pages 989-994

5-HT2C receptor agonists with potential anorectic activity

(4) Yoon, Goo a Jeong, Hee Jin a Kim, Jeong Ju a Cheon, Seung Hoon a

a Chonnam National University (South Korea)

Author keywords

5HT2C receptor agonist; Anorectic; Obesity; Pyrazinobenoxazinone

Indexed keywords

ANOREXIGENIC AGENT; BENZOXAZINE DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; PYRAZINE DERIVATIVE; SEROTONIN 2C RECEPTOR; SEROTONIN AGONIST;

ANIMAL; ARTICLE; CHO CELL; CRICETULUS; DRUG EFFECT; HAMSTER; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; THIN LAYER CHROMATOGRAPHY;

ANIMALS; APPETITE DEPRESSANTS; BENZOXAZINES; CHO CELLS; CHROMATOGRAPHY, THIN LAYER; CRICETINAE; CRICETULUS; HUMANS; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; PYRAZINES; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN AGONISTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 51849168659 PISSN: 02536269 EISSN: 19763786 Source Type: Journal
DOI: 10.1007/s12272-001-1257-7 Document Type: Article

Times cited : (5)

References (13)

1
- 33745872950
- CB1 Cannabinoid receptor antagonists for treatment of obesity and prevention of comorbid metabolic disorders
- J. Antel P. C. Gregory U. Nordheim 2006 CB1 Cannabinoid receptor antagonists for treatment of obesity and prevention of comorbid metabolic disorders J. Med. Chem. 49 4008 4016
- (2006) J. Med. Chem. , vol.49 , pp. 4008-4016
- Antel, J.¹ Gregory, P.C.² Nordheim, U.³

2
- 33645384224
- A green and facile route to γ-and δ-lactones via efficient Pinnercyclization of hydroxynitriles in water
- K. Aplander O. Hidestal K. Katebzadeh U. M. Lindstrom 2006 A green and facile route to γ-and δ-lactones via efficient Pinnercyclization of hydroxynitriles in water Green Chem. 8 22 24
- (2006) Green Chem. , vol.8 , pp. 22-24
- Aplander, K.¹ Hidestal, O.² Katebzadeh, K.³ Lindstrom, U.M.⁴

3
- 0037646298
- 2C receptor agonists as potential drugs for the treatment of obesity
- 2C receptor agonists as potential drugs for the treatment of obesity Curr. Top. Med. Chem. 3 885 897
- (2003) Curr. Top. Med. Chem. , vol.3 , pp. 885-897
- Bickerdike, M.J.¹

4
- 0033157213
- 2C receptor modulation and the treatment of obesity
- 2C receptor modulation and the treatment of obesity Diabetes Obes. Metab. 1 207 14
- (1999) Diabetes Obes. Metab. , vol.1 , pp. 207-14
- Bickerdike, M.J.¹ Vickers, S.P.² Dourish, C.T.³

5
- 33745807267
- Obesity: The disease
- G. A. Bray 2006 Obesity: The disease J. Med. Chem. 49 4001 4007
- (2006) J. Med. Chem. , vol.49 , pp. 4001-4007
- Bray, G.A.¹

6
- 0030876952
- Valvular, heart disease associated with fenfluramine-phentermine
- M. H. Connolly J. L. Crary M. D. Mcgoon D. D. Hensrud B. S. Edwards W. D. Edwards H. V. Schaff 1997 Valvular, heart disease associated with fenfluramine-phentermine New. Enlg. J. Med. 337 581 588
- (1997) New. Enlg. J. Med. , vol.337 , pp. 581-588
- Connolly, M.H.¹ Crary, J.L.² McGoon, M.D.³ Hensrud, D.D.⁴ Edwards, B.S.⁵ Edwards, W.D.⁶ Schaff, H.V.⁷

7
- 33745887202
- Melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity
- A. L. Handlon A. H. Zhou 2006 Melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity J. Med. Chem. 49 4017 4022
- (2006) J. Med. Chem. , vol.49 , pp. 4017-4022
- Handlon, A.L.¹ Zhou, A.H.²

8
- 33745224538
- An improved synthesis of Lu AA20465
- E. A. Krafft E. Pinard A. W. Thomas 2006 An improved synthesis of Lu AA20465 Tet. Lett. 47 5355 5357
- (2006) Tet. Lett. , vol.47 , pp. 5355-5357
- Krafft, E.A.¹ Pinard, E.² Thomas, A.W.³

9
- 15944367788
- Meta-analysis: Pharmacologic treatment of obesity
- Z. Li M. Maglione W. Tu W. Mojica D. Aterburn L. Shugarman L. Hilton M. Suttorp V. Solomon P. G. Shekelee S. C. Morton 2005 Meta-analysis: Pharmacologic treatment of obesity Ann. Intern. Med. 142 532 546
- (2005) Ann. Intern. Med. , vol.142 , pp. 532-546
- Li, Z.¹ Maglione, M.² Tu, W.³ Mojica, W.⁴ Aterburn, D.⁵ Shugarman, L.⁶ Hilton, L.⁷ Suttorp, M.⁸ Solomon, V.⁹ Shekelee, P.G.¹⁰ Morton, S.C.¹¹

10
- 33745827397
- Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity
- R. P. Nargund A. M. Strack T. M. Fong 2006 Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity J. Med. Chem. 49 4035 4043
- (2006) J. Med. Chem. , vol.49 , pp. 4035-4043
- Nargund, R.P.¹ Strack, A.M.² Fong, T.M.³

11
- 33745838246
- 2C) receptor agonists as potential antiobesity agents
- 2C) receptor agonists as potential antiobesity agents J. Med. Chem. 49 4023 4034
- (2006) J. Med. Chem. , vol.49 , pp. 4023-4034
- Nilsson, B.M.¹

12
- 0030609003
- 2C receptor activation decreases appetite and body weight in obese subjects
- 2C receptor activation decreases appetite and body weight in obese subjects Psychopharmacology (Berlin) 133 309 312
- (1997) Psychopharmacology (Berlin) , vol.133 , pp. 309-312
- Sargent, P.A.¹ Sharpley, A.L.² Williams, C.³ Goodall, E.M.⁴ Cowen, P.J.⁵

13
- 0034605255
- Synthesis and 5-hydroxytryptamine (5-HT) activity of 2,3,4,4a-tetrahydro- 1Hpyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[1, 2-a]quinoxalines
- G. S. Welmaker J. A. Nelson J. E. Sabalski A. L. Sabb J. R. Potoski D. Graziano M. Kagan J. Coupet J. Dunlop H. Mazandarani S. Rosenzweig-Lipson S. Sukoff Y. Zhang 2000 Synthesis and 5-hydroxytryptamine (5-HT) activity of 2,3,4,4a-tetrahydro-1Hpyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[1,2-a]quinoxalines Bioorg. & Med. Chem. Lett. 10 1991 1994
- (2000) Bioorg. & Med. Chem. Lett. , vol.10 , pp. 1991-1994
- Welmaker, G.S.¹ Nelson, J.A.² Sabalski, J.E.³ Sabb, A.L.⁴ Potoski, J.R.⁵ Graziano, D.⁶ Kagan, M.⁷ Coupet, J.⁸ Dunlop, J.⁹ Mazandarani, H.¹⁰ Rosenzweig-Lipson, S.¹¹ Sukoff, S.¹² Zhang, Y.¹³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.